Results 31 to 40 of about 469,365 (378)

Vaccinal Preventon of Anthrax in the Russian Federation and Its Immediate Prospects

Вестник войск РХБ защиты, 2023
The purpose of the work is to show the possibilities of vaccine prophylaxis of anthrax in the Russian Federation and its immediate prospects. The article is dedicated to the vaccine preparations, available in Russia and abroad in the arsenal of medical ...
A. N. Shevtsov, O. V. Korotyshev, S. A. Permyakov, I. P. Pogorelsky   +3 more
doaj   +1 more source

Recombinant anticoccidial vaccines - a cup half full? [PDF]

, 2017
Eimeria species parasites can cause the disease coccidiosis, most notably in chickens. The occurrence of coccidiosis is currently controlled through a combination of good husbandry, chemoprophylaxis and/or live parasite vaccination; however, scalable ...
Ahmad, Arnott, Awad, Bafundo, Blake, Blake, Blake, Brothers, Brown, Chapman, Chapman, Chapman, Chapman, Chapman, Chapman, Chapman, Chapman, Chen, Clark, Clark, Cornelissen, Cosentino, Crane, Dalloul, Damer P. Blake, Ding, Ding, Djemai, Du, Eckford, Fiona M. Tomley, Fischbach, Fluit, Gedik, Gowen, Hedhli, Hoan, Huang, Iván Pastor-Fernández, Jahn, Jang, Jang, Jenkins, Jenkins, Jenkins, Jiang, Joyner, Karlsson, Keestra, Klotz, Koblansky, Konjufca, Kundu, Kvicerova, Labbe, Lai, Lassen, Lee, Li, Li, Lillehoj, Liu, Long, Marugan-Hernandez, Matthew J. Nolan, McDonald, McDonald, Min, Naciri, Nolan, Peek, Peek, Plattner, Pogonka, Reid, Ruff, Rugarabamu, Salazar Gonzalez, Sathish, Schaap, Shah, Sharman, Shen, Shirley, Shirley, Smith, Song, Song, Song, Song, Song, Song, Song, Subramanian, Sun, Takala, Tang, Tomley, Tomley, Tomley, Vermeulen, Vrba, Wallach, Wang, Wang, Williams, Williams, Williams, Williams, Williams, Witcombe, Wu, Xu, Xu, Yin, Yin, Yun, Zhang, Zhang, Zimmermann   +119 more
core   +1 more source

Protective Antigen-Specific Memory B Cells Persist Years after Anthrax Vaccination and Correlate with Humoral Immunity

Toxins, 2014
Anthrax Vaccine Adsorbed (AVA) generates short-lived protective antigen (PA) specific IgG that correlates with in vitro toxin neutralization and protection from Bacillus anthracis challenge.
Lori Garman, Kenneth Smith, A. Darise Farris, Michael R. Nelson, Renata J. M. Engler, Judith A. James   +5 more
doaj   +1 more source

Vaccines against toxoplasma gondii : challenges and opportunities [PDF]

, 2009
Development of vaccines against Toxoplasma gondii infection in humans is of high priority, given the high burden of disease in some areas of the world like South America, and the lack of effective drugs with few adverse effects.
Aliberti J, Angus CW, Aosai F, Aosai F, Awan KJ, Beghetto E, Bommireddy R, Bonenfant C, Boyle JP, Brinkmann V, Buxton D, Bülow R, Caetano BC, Conacher M, Cong H, Cong H, Constant SL, Couper KN, Craig W Roberts, Cui YL, Cuppari AF, Curtsinger JM, Curtsinger JM, Cutchins EC, Darcy F, Dautu G, Debard N, Debierre-Grockiego F, DeGregorio E, Denkers EY, Desolme B, Duquesne V, Echeverria PC, Elisabeth Förster-Waldl, Erik Jongert, Escajadillo A, Eskild Petersen, Fachado A, Fachado A, Flori P, Fox B, Frenkel JK, Garcia JL, Garcia JL, Gatkowska J, Gazzinelli R, Gazzinelli RT, Golkar M, Hakim FT, Igarashi M, Innes EA, Ishii K, Ishii KJ, Ismael AB, Ismael AB, Johnson LL, Jongert E, Jongert E, Jongert E, Kasper LH, Khan IA, Kijlstra A, Kodjikian L, Krahenbuhl JL, Kringel H, Letscher-Bru V, Letscher-Bru V, Leyva R, Lindsay DS, Liu Q, Lourenco EV, Lourenço EV, Martin V, McLeod R, Mishima M, Mishima M, Mohamed RM, Mévélec MN, Mévélec MN, Nicola Gargano, Nielsen HV, Nielsen HV, Petersen E, Petrovsky N, Pettersen EK, Pfefferkorn ER, Qu D, Reikvam A, Roque-Resendiz JL, Sabin AB, Sayles PC, Schaap D, Scorza T, Siachoque H, Sibley LD, Silveira C, Stanley AC, Stockinger B, Supply P, Taneja V, Vandepapelierea P, Velge-Roussel F, Velge-Roussel F, Vercammen M, Vogel N, Vyas JM, Waldeland H, Wang H, Wilkins MF, Williams MA, Xue M, Xue M, Yang CD, Yarovinsky F, Zenner L, Zhang G, Zhang J, Zimmermann S   +117 more
core   +3 more sources

VaxiJen: a server for prediction of protective antigens, tumour antigens and subunit vaccines [PDF]

BMC Bioinformatics, 2007
Vaccine development in the post-genomic era often begins with the in silico screening of genome information, with the most probable protective antigens being predicted rather than requiring causative microorganisms to be grown. Despite the obvious advantages of this approach--such as speed and cost efficiency--its success remains dependent on the ...
Irini Doytchinova, Darren R. Flower
openaire   +5 more sources

Rapid and Sensitive Multiplex Assay for the Detection of B. anthracis Spores from Environmental Samples

Pathogens, 2020
: Prompt and accurate detection of Bacillus anthracis spores is crucial in the event of intentional spore dissemination in order to reduce the number of expected casualties.
Efi Makdasi, Orly Laskar, Itai Glinert, Ron Alcalay, Adva Mechaly, Haim Levy   +5 more
doaj   +1 more source

Expression and refolding of the protective antigen of Bacillus anthracis: A model for high-throughput screening of antigenic recombinant protein refolding [PDF]

, 2016
Bacillus anthracis protective antigen (PA) is a well known and relevant immunogenicprotein that is the basis for both anthrax vaccines and diagnostic methods. Properly foldedantigenic PA is necessary for these applications.
Cairo, Fabian Martin, Pavan, Esteban E., Pavan, María Elisa, Pettinari, María Julia   +3 more
core   +1 more source

Molecular tug of war reveals adaptive potential of an immune cell repertoire [PDF]

arXiv, 2022
The adaptive immune system constantly remodels its lymphocyte repertoire for better protection against future pathogens. Its ability to improve antigen recognition on the fly relies on somatic mutation and selective expansion of B lymphocytes expressing high-affinity antigen receptors.
arxiv  

A graph model for the evolution of specificity in humoral immunity [PDF]

Journal of Theoretical Biology 229 (2004), 311-325, 2003
The immune system protects the body against health-threatening entities, known as antigens, through very complex interactions involving the antigens and the system's own entities. One remarkable feature resulting from such interactions is the immune system's ability to improve its capability to fight antigens commonly found in the individual's ...
arxiv   +1 more source

Computational model for tumor response to adoptive cell transfer therapy [PDF]

arXiv, 2022
One of the barriers to the development of effective adoptive cell transfer therapies (ACT), specifically for genetically engineered T-cell receptors (TCRs), and chimeric antigen receptor (CAR) T-cells, is target antigen heterogeneity. It is thought that intratumor heterogeneity is one of the leading determinants of therapeutic resistance and treatment ...
arxiv